Help Us Study a New Treatment Option for OCD
Would you like to take part in a clinical trial for a new investigational medication for people suffering with OCD?
Why Join Us
We need your help in our mission to successfully develop the first new medication for OCD since the mid-1990s.
You will receive study-related care and evaluations of your OCD-related symptoms at no cost to you (no insurance required).
You may receive compensation for time and travel to attend study visits.
The Process to See If You Qualify
If you have been diagnosed with OCD, or think you may have symptoms, are between 18 & 65 years of age, and are not taking the SSRI medication: Fluvoxamine (Luvox), please take the next 3 steps below:
Select the clinic that is most convenient for you.
Use the provided information to call or email the clinic.
Study clinicians will assess your eligibility, and discuss possible next steps.
Call or email the nearest clinic below for more information.
MAC Clinical Research – Lancashire
Kaman Court, 1 Faraday Way
Blackpool, FY2 0JH
Ellice Partington, Study Coordinator
Greater Manchester Mental Health NHS Foundation Trust
3rd Floor, Rawnsley Building, Hathersage Road
Manchester, M13 9WL
Leanne Howieson, Study Coordinator
MAC Clinical Research – Greater Manchester
Neuroscience Centre of Excellence, Citylabs, Nelson Street
Manchester, M13 9NQ
Sukoluhle Mguni, Site Director
MAC Clinical Research – Merseyside
11 Tiger Court, Kings Drive, King’s Business Park, Prescot
Merseyside, L34 1BH
Grace Austin, Study Coordinator
Bioluminux Ltd.
15 Diamond Court, Opal Drive, Fox Milne
Milton Keynes, MK15 0DU
Orsolya Lawrence, Director of Clinical Operations and Business Development
Stemax Consult Healthcare Services Ltd
Unit F, Old Stratford Business Park, Falcon Drive, Off Stony Stratford Road Northamptonshire, MK19 6FG
Olu bunmi Ijeh, Site Director
admin@stemaxconsult.com
01908 032 992
Cornwall Partnership NHS Foundation Trust
The Kernow Building, Wilson Way, Pool
Redruth, TR15 3QE
Richard Higgins, Senior Research Nurse
richard.higgins2@nhs.net
01209 204020
MAC Clinical Research – Stockton-on-Tees
GAC House, Sabatier Close
Stockton-on-Tees, TS17 6EW
Jessica Regan, Study Coordinator
MAC Clinical Research – South Staffordshire
Exchange House, Watling Street – Cannock
South Staffordshire, WS11 0BN
Alice Allen, Study Coordinator
MAC Clinical Research – South Yorkshire
Phoenix House, Maple Road
Tankersley, S75 3DL
Jodie Lanceley, Study Coordinator
MAC Clinical Research – Leeds
Monarch House, Wakefield Road, Leeds
Yorkshire, LS10 1DU
Ryan Williams, Study Coordinator
About Biohaven
Biohaven Pharmaceuticals in New Haven, Connecticut, is the sponsor of the study. Biohaven researches a range of neurological and neurobiological disorders, and obsessive-compulsive disorder is an important focus of their work.
